Overview

Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers

Status:
Completed
Trial end date:
2017-01-26
Target enrollment:
Participant gender:
Summary
Unifusol (R) is a solution of arginine sodium succinate for intravenous infusions. Its effects include vasodilation, protection of inner layer of blood vessels and improvement of blood viscosity. The present phase I study is aimed to evaluate the safety and tolerability of Unifusol infusions in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
POLYSAN Scientific & Technological Pharmaceutical Company
Scientific Technological Pharmaceutical Firm Polysan, Ltd.
Treatments:
Pharmaceutical Solutions